NUCLEUS.BO(NUCLEUS.BO)
NUCLEUS.BO
No analyst ratings available
No analyst price targets available for NUCLEUS.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $9.50B | $10.40B |
| Low | $9.50B | $10.40B |
| High | $9.50B | $10.40B |
| EBITDA Avg | $2.12B | $2.32B |
| Low | $2.12B | $2.32B |
| High | $2.12B | $2.32B |
| EBIT Avg | $1.91B | $2.09B |
| Low | $1.91B | $2.09B |
| High | $1.91B | $2.09B |
| Net Income Avg | $1.52B | $1.68B |
| Low | $1.52B | $1.68B |
| High | $1.52B | $1.68B |
| EPS Avg | $57.70 | $63.90 |
| Low | $57.70 | $63.90 |
| High | $57.70 | $63.90 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |